UK Healthcare Stocks
34 UK-listed Healthcare companies with a combined market capitalisation of £316.13B. The largest is AstraZeneca PLC (AZN) — 12 AIM, 9 FTSE AIM 100, 6 FTSE 250, 5 FTSE 100, 2 FTSE SmallCap.
All companiesBasic MaterialsCommunication ServicesConsumer CyclicalConsumer DefensiveEnergyFinancial ServicesIndustrialsReal EstateTechnologyUtilities
| Company | Ticker | Index | Market cap |
|---|---|---|---|
| AstraZeneca PLC | AZN | FTSE 100 | £185.64B |
| GSK plc | GSK | FTSE 100 | £73.96B |
| Haleon plc | HLN | FTSE 100 | £29.36B |
| Smith & Nephew plc | SN | FTSE 100 | £8.79B |
| Convatec Group PLC | CTEC | FTSE 100 | £4.43B |
| Hikma Pharmaceuticals PLC | HIK | FTSE 250 | £3.31B |
| Oxford Nanopore Technologies plc | ONT | FTSE 250 | £1.56B |
| Genus plc | GNS | FTSE 250 | £1.37B |
| Spire Healthcare Group plc | SPI | FTSE 250 | £983.47M |
| Uniphar plc | UPR | FTSE AIM 100 | £978.28M |
| CVS Group plc | CVSG | FTSE 250 | £868.42M |
| Advanced Medical Solutions Group plc | AMS | FTSE AIM 100 | £610.38M |
| Oxford Biomedica plc | OXB | FTSE 250 | £561.79M |
| Craneware plc | CRW | FTSE AIM 100 | £452.07M |
| International Biotechnology Ord | IBT | FTSE SmallCap | £353.86M |
| Allergy Therapeutics plc | AGY | AIM | £329.29M |
| Avacta Group Plc | AVCT | FTSE AIM 100 | £310.56M |
| PureTech Health plc | PRTC | FTSE SmallCap | £291.13M |
| NIOX Group Plc | NIOX | FTSE AIM 100 | £284.51M |
| Optima Health plc | OPT | FTSE AIM 100 | £267.59M |
| Animalcare Group PLC | ANCR | FTSE AIM 100 | £231.30M |
| Tristel plc | TSTL | FTSE AIM 100 | £197.58M |
| Scancell Holdings plc | SCLP | FTSE AIM 100 | £140.96M |
| Diaceutics PLC | DXRX | AIM | £122.71M |
| EKF Diagnostics Holdings plc | EKF | AIM | £108.34M |
| INSPECS Group plc | SPEC | AIM | £101.26M |
| Bioventix PLC | BVXP | AIM | £86.99M |
| 4basebio PLC | 4BB | AIM | £73.64M |
| Kooth plc | KOO | AIM | £66.65M |
| ECO Animal Health Group plc | EAH | AIM | £63.39M |
| Creo Medical Group PLC | CREO | AIM | £60.12M |
| Poolbeg Pharma PLC | POLB | AIM | £59.01M |
| Shield Therapeutics plc | STX | AIM | £49.86M |
| hVIVO plc | HVO | AIM | £47.50M |